A randomized comparison of cyclophosphamide vs. reduced dose cyclophosphamide plus fludarabine for allogeneic hematopoietic cell transplantation in patients with aplastic anemia and hypoplastic myelodysplastic syndrome

Annals of Hematology

Volumn 91, Issue 9, 2012, Pages 1459-1469

  Kim, Hawk ^a   Lee, Je Hwan ^a   Joo, Young Don ^b   Bae, Sung Hwa ^c   Hyun, Myung Soo ^d   Lee, Jung Hee ^a   Kim, Dae Young ^a   Lee, Won Sik ^b   Ryoo, Hun Mo ^c   Kim, Min Kyoung ^d   Park, Jae Hoo ^a   Lee, Kyoo Hyung ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Inje University College of Medicine   (South Korea)

^c Catholic University of Daegu   (South Korea)

^d Young Nam University Hospital   (South Korea)

Author keywords

Aplastic anemia; Conditioning; Cyclophosphamide; Fludarabine; Myelodysplastic syndrome; Transplantation

Indexed keywords

ACICLOVIR; AMOXICILLIN; CIPROFLOXACIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; IMMUNOGLOBULIN; LYMPHOCYTE ANTIBODY; METHOTREXATE; PENTAMIDINE; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; BACTERIAL PNEUMONIA; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG FATALITY; DRUG FEVER; FEMALE; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HEMATURIA; HERPES SIMPLEX; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LIVER VENOOCCLUSIVE DISEASE; LUNG DISEASE; LUNG EDEMA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PHASE 3 CLINICAL TRIAL; PLEURA EFFUSION; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE;

ADOLESCENT; ADULT; ANEMIA, APLASTIC; ANTIBIOTIC PROPHYLAXIS; ANTILYMPHOCYTE SERUM; ANTIVIRAL AGENTS; CYCLOPHOSPHAMIDE; FEMALE; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYELOABLATIVE AGONISTS; MYELODYSPLASTIC SYNDROMES; POSTOPERATIVE COMPLICATIONS; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; VIDARABINE; YOUNG ADULT;

EID: 84864916712     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-012-1462-x     Document Type: Article

References (24)

1. Ades L, Mary JY, Robin M, Ferry C, Porcher R, Esperou H, Ribaud P, Devergie A, Traineau R, Gluckman E, Socie G (2004) Long-term outcome after bone marrow transplantation for severe aplastic anemia. Blood 103:2490-2497
2. Anderlini P, Acholonu SA, Okoroji GJ, Bassett RE, Shpall EJ, Qazilbash MH, Popat UR, Worth LL, Giralt SA, Champlin RE (2011) Fludarabine, cyclophosphamide, and antithymocyte globulin for matched related and unrelated allogeneic stem cell transplant in severe aplastic anemia. Leuk Lymphoma 52:137-141
3. Armitage JO (1994) Bone marrow transplantation. N Engl J Med 330:827-838
4. Bacigalupo A, Locatelli F, Lanino E, Marsh J, Socie G, Maury S, Prete A, Locasciulli A, Cesaro S, Passweg J (2005) Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAAworking party. Bone Marrow Transplant 36:947-950
5. Cleland BD, Pokorny CS (1993) Cyclophosphamide related hepatotoxicity. Australian and New Zealand journal of medicine 23:408
6. Deeg HJ, Seidel K, Casper J, Anasetti C, Davies S, Gajeweski JL, Territo M, Ramsay N, Harris RE, Catro-Malaspina H, Collins R, Champlin R, Schoch G, King R, Howe C (1999) Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy. Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant 5:243-252
7. DeLeve LD (1996) Cellular target of cyclophosphamide toxicity in the murine liver: role of glutathione and site of metabolic activation. Hepatology 24:830-837
8. Goldberg JW, Lidsky MD (1985) Cyclophosphamide-associated hepatotoxicity. South Med J 78:222-223
9. Goligher EC, Cserti-Gazdewich C, Balter M, Gupta V, Brandwein JE (2009) Acute lung injury during antithymocyte globulin therapy for aplastic anemia. Can Respir J 16:e3-5
10. Kang HJ, Shin HY, Choi HS, Ahn HS (2004) Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia. Bone Marrow Transplant 34:939-943
11. Kim H, Kim BS, Kim DH, Hyun MS, Kim SH, Bae SH, Choi JH, Sohn SK, Shin HJ, Won JH, Yoon SS, Jo DY, Joo YD, Park JH, Lee KH, Transplantation oboTKSoBaM (2011 Jan 8. [Epub ahead of print]) Comparison between matched related and alternative donors of allogeneic hematopoietic stem cells transplanted into Adult patients with acquired aplastic anemia: multivariate and propensity score-matched analysis. Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant
12. Kojima S, Matsuyama T, Kato S, Kigasawa H, Kobayashi R, Kikuta A, Sakamaki H, Ikuta K, Tsuchida M, Hoshi Y, Morishima Y, Kodera Y (2002) Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program. Blood 100:799-803
13. Lee JH, Lee JS, Kim WK, Chi HS, Lee KH (2001) Cyclophosphamide and antithymocyte globulin conditioning may be sufficient for Korean patients with early stage severe aplastic anemia transplanted with marrow from donors other than HLAidentical siblings. Haematologica 86:434-435
14. Lee JH, Lee KH, Choi SJ, Min YJ, Kim JG, Kim S, Lee JS, Kim SH, Park CJ, Chi HS, Kim WK (2000) Veno-occlusive disease of the liver after allogeneic bone marrow transplantation for severe aplastic anemia. Bone Marrow Transplant 26:657-662
15. Lee JW, Cho BS, Lee SE, Eom KS, Kim YJ, Kim HJ, Lee S, Min CK, Cho SG, Min WS, Park CW (2011) The outcome of unrelated hematopoietic stem cell transplants with total body irradiation (800cGy) and cyclophosphamide (120 mg/kg) in Adult patients with acquired severe aplastic anemia. Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant 17:101-108
16. Maury S, Bacigalupo A, Anderlini P, Aljurf M, Marsh J, Socie G, Oneto R, Passweg JR (2009) Improved outcome of patients older than 30 years receiving HLA-identical sibling hematopoietic stem cell transplantation for severe acquired aplastic anemia using fludarabine- based conditioning: a comparison with conventional conditioning regimen. Haematologica 94:1312-1315
17. McDonald GB, Hinds MS, Fisher LD, Schoch HG, Wolford JL, Banaji M, Hardin BJ, Shulman HM, Clift RA (1993) Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 118:255-267
18. Modzelewski JR Jr, Daeschner C, Joshi VV, Mullick FG, Ishak KG (1994) Veno-occlusive disease of the liver induced by low-dose cyclophosphamide. Modern Pathol: Off J U S Can Acad Pathol, Inc 7:967-972
19. Oberoi S, Bansal D, Sharma RR, Gautam V, Marwaha N, Marwaha RK (2011) Antithymocyte globulin-induced acute lung injury during transplantation for aplastic anemia. J Pediatr Hematol Oncol 33:150-152
20. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, Thomas ED (1995) 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant 15:825-828
21. Seber A, Shu XO, Defor T, Sencer S, Ramsay N (1999) Risk factors for severe hemorrhagic cystitis following BMT. Bone Marrow Transplant 23:35-40
22. Slattery JT, Kalhorn TF, McDonald GB, Lambert K, Buckner CD, Bensinger WI, Anasetti C, Appelbaum FR (1996) Conditioning regimen-dependent disposition of cyclophosphamide and hydroxycyclophosphamide in human marrow transplantation patients. J Clin Oncol: Off J Am Soc Clin Oncol 14:1484-1494
23. Storb R, Etzioni R, Anasetti C, Appelbaum FR, Buckner CD, Bensinger W, Bryant E, Clift R, Deeg HJ, Doney K et al (1994) Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. Blood 84:941-949
24. Storb R, Leisenring W, Anasetti C, Appelbaum FR, Buckner CD, Bensinger WI, Chauncey T, Clift RA, Deeg HJ, Doney KC, Flowers ME, Hansen JA, Martin PJ, Sanders JE, Sullivan KM, Witherspoon RP (1997) Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulin. Blood 89:3890-3891